Clinical Study

Comparison of Diagnostic Performance of Three-Dimensional Positron Emission Mammography versus Whole Body Positron Emission Tomography in Breast Cancer

Table 2

Baseline clinical characteristics.

3D-PEM-WBPET
(n = 204)
WBPET-3D-PEM
(n = 200)
P valueTotal
(N = 404)

Age (years)
 Mean ± SD50.1 ± 9.351.1 ± 9.10.266350.6 ± 9.2
 Median (min, max)50.0 (19.0, 71.0)51.0 (20.0, 70.0)50.0 (19.0, 71.0)
BMI (kg/m2)
 Mean ± SD24.3 ± 3.424.5 ± 3.70.606124.4 ± 3.6
 Median (min, max)24.1 (17.3, 39.7)24.2 (15.9, 43.0)24.2 (15.9, 43.0)
SBP (mmHg)
 Mean ± SD120.3 ± 12.1122.5 ± 15.30.1075121.4 ± 13.8
 Median (min, max)120.0 (87.0, 160.0)120.0 (87.0, 180.0)120.0 (87.0, 180.0)
DBP (mmHg)
 Mean ± SD77.4 ± 7.978.1 ± 8.60.391377.7 ± 8.2
 Median (min, max)80.0 (51.0, 109.0)80.0 (53.0, 100.0)80.0 (51.0, 109.0)
Comorbidities, n
 Diabetes mellitus9.7% (11/113)11.7 (13/111)0.6323
 Uterine fibroids48.9% (23/47)55.9% (19/34)0.5366

SBP: systolic blood pressure; DBP: diastolic blood pressure; SD: standard deviation; BMI: body mass index. Values in the 2 groups were compared by Student’s t-test or chi-square or Fisher’s exact test.